Evidence map›Paper›PMID 28338294›Full record

ArticleJournal of cellular and molecular medicine2017

Paradoxical gain-of-function mutant of the G-protein-coupled receptor PROKR2 promotes early puberty.

Maki Fukami, Erina Suzuki, Yoko Izumi, Tomohiro Torii, Satoshi Narumi, Maki Igarashi, Mami Miyado, Momori Katsumi, Yasuko Fujisawa, Kazuhiko Nakabayashi and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of cellular and molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Genetic causes of central precocious puberty.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2022
    Review
  9. Review
  10. Methylation status of hypothalamicFrontiers in endocrinology · 2022
    Article
  11. Observational
  12. Article
  13. Article
  14. (Epi)genetic defects ofHuman genome variation · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.ORCID 0000-0001-9971-4035
Erina SuzukiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Yoko IzumiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Tomohiro ToriiDepartment of Pharmacology, National Research Institute for Child Health and Development, Tokyo, Japan.
Satoshi NarumiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Maki IgarashiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Mami MiyadoDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Momori KatsumiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Yasuko FujisawaDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kazuhiko NakabayashiDepartment of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.
Kenichiro HataDepartment of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.
Akihiro UmezawaDepartment of Reproductive Biology, Center for Regenerative Medicine, National Institute for Child Health and Development, Tokyo, Japan.
Yoichi MatsubaraNational Research Institute for Child Health and Development, Tokyo, Japan.
Junji YamauchiDepartment of Pharmacology, National Research Institute for Child Health and Development, Tokyo, Japan.
Tsutomu OgataDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
National Center For Child Health and Development · JPHamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human genome encodes ~750 G-protein-coupled receptors (GPCRs), including prokineticin receptor 2 (PROKR2) involved in the regulation of sexual maturation. Previously reported pathogenic gain-of-function mutations of GPCR genes invariably encoded aberrant receptors with excessive signal transduction activity. Although in vitro assays demonstrated that an artificially created inactive mutant of PROKR2 exerted paradoxical gain-of-function effects when co-transfected with wild-type proteins, such a phenomenon has not been observed in vivo. Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The mutant mRNA escaped nonsense-mediated decay and generated a GPCR lacking two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca

Indexed as

Frameshift MutationGain of Function MutationBase SequenceChild, PreschoolDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseHumansPuberty, PrecociousReceptors, G-Protein-CoupledReceptors, PeptideSequence DeletionPROKR2 protein, humanReceptors, G-Protein-CoupledReceptors, PeptideGPCRmutationneuroendocrine

Identifiers

PMID28338294
PMCPMC5618689
OpenAlexW2600812296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.